Acthrel
Product Images NDC 55566-0302

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acthrel (NDC 55566-0302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acthrelcortisonechart (Acthrel 01)

Acthrelcortisonechart (Acthrel 01)
This appears to be a graph or chart with hormone levels measured over time. The hormones measured are CRH, ACTH, and cortisol. The units of measurement for CRH is not specified, but ACTH is measured in pg/mL and cortisol is measured in ug/dL. The x-axis indicates time in hours with measurements taken at 8:00 am in 2000. Further interpretation or evaluation cannot be done without additional information.*
FDA Label Image

Principal Display Panel (100 mcg Vial Label)

Principal Display Panel (100 mcg Vial Label)
This is a description of medicine labeled as ACTHREL® NDC 55566-0302-1. It contains corticorelin ovine triflutate for injection along with lactose, ascorbic acid, and cysteine hydrochloride monohydrate. It is intended for intravenous use only and should be reconstituted with sodium chloride injection before use, which should be protected from light. The dosage is available on the package insert, and it should be stored at a temperature between 2° to 8°C. The medicine is manufactured in Germany by Ferring Pharmaceuticals, Inc. with a lot number and expiration date mentioned.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.